Case Study

Reducing Time To PPQ By More Than 25%: Successful Tech Transfer Meets Commercial Needs

Source: AbbVie

By Tracey Townsend, Associate Director, and Jozef Blaszczyk, Account Manager

GettyImages-2258304529-scientist-with-vial-and-tubing-in-lab

Accelerating a technology transfer late in development can be critical when market demand outpaces existing manufacturing capacity. This case study explores how an experienced manufacturing partner condensed a traditionally 12–18 month tech transfer timeline to just nine months while preparing a complex biologic for commercial supply.
The program faced multiple, overlapping challenges: onboarding more than a dozen novel raw materials, qualifying new suppliers, navigating proprietary material authorization delays, and implementing enhanced intellectual property protections that required specialized training for a large cross‑functional team. Complicating matters further, emerging stability data during the first PPQ campaign revealed an opportunity for late‑stage process optimization to extend shelf life.
Rather than slowing progress, teams executed parallel workstreams—advancing regulatory filings while simultaneously optimizing the process and completing a second PPQ run. Both PPQ campaigns were approved for commercial use. The result was a significantly compressed path to validated manufacturing, enabling timely product availability while maintaining regulatory rigor, data integrity, and long‑term process robustness.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma